A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms

Glenner GG, Wong CW . Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120: 885–890.

Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K . Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc Natl Acad Sci USA 1985; 82: 4245–4249.

Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733–736.

Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC . Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 1987; 235: 877–880.

Tanzi RE, Gusella JF, Watkins PC, Bruns GA, StGeorge-Hyslop O, Van Keuren ML et al. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 1987; 235: 880–884.

Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B et al. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 1988; 331: 525–527.

Schmaier AH, Dahl LD, Rozemuller AJ, Roos RA, Wagner SL, Chung R et al. Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa. J Clin Invest 1993; 92: 2540–2545.

Van Nostrand WE, Schmaier AH, Wagner SL . Potential role of protease nexin-2/amyloid beta-protein precursor as a cerebral anticoagulant. Ann NY Acad Sci 1992; 674: 243–252.

Mahdi F, Van Nostrand WE, Schmaier AH . Protease nexin-2/amyloid beta-protein precursor inhibits factor Xa in the prothrombinase complex. J Biol Chem 1995; 270: 23468–23474.

Sinha S, Lieberburg I . Cellular mechanisms of beta-amyloid production and secretion. Proc Natl Acad Sci USA 1999; 96: 11049–11053.

Graveley BR . Alternative splicing: increasing diversity in the proteomic world. Trends Genet 2001; 17: 100–107.

Modrek B, Lee C . A genomic view of alternative splicing. Nat Genet 2002; 30: 13–19.

Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003; 302: 2141–2144.

Smith CW, Valcarcel J . Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem Sci 2000; 25: 381–388.

Singh NN, Androphy EJ, Singh RN . The regulation and regulatory activities of alternative splicing of the SMN gene. Crit Rev Eukaryot Gene Expr 2004; 14: 271–285.

Tsukahara T, Kunika N, Momoi T, Arahata K . Regulation of alternative splicing in the amyloid precursor protein (APP) mRNA during neuronal and glial differentiation of P19 embryonal carcinoma cells. Brain Res 1995; 679: 178–183.

Shibata A, Hattori M, Suda H, Sakaki Y . Identification of cis-acting elements involved in an alternative splicing of the amyloid precursor protein (APP) gene. Gene 1996; 175: 203–208.

Poleev A, Hartmann A, Stamm S . A trans-acting factor, isolated by the three-hybrid system that influences alternative splicing of the amyloid precursor protein minigene. Eur J Biochem 2000; 267: 4002–4010.

Paquet-Durand F, Tan S, Bicker G . Turning teratocarcinoma cells into neurons: rapid differentiation of NT-2 cells in floating spheres. Brain Res Dev Brain Res 2003; 142: 161–167.

Donev R, Horton R, Beck S, Doneva T, Vatcheva R, Bowen WR et al. Recruitment of heterogeneous nuclear ribonucleoprotein A1 in vivo to the LMP/TAP region of the major histocompatibility complex. J Biol Chem 2003; 278: 5214–5226.

Bonnal S, Pileur F, Parker F, Pujol F, Prats AC, Vagner S . Heterogeneous nuclear ribonucleoprotein A1 is a novel internal ribosome entry site trans-acting factor that modulates alternative initiation of translation of the fibroblast growth factor 2 mRNA. J Biol Chem 2005; 280: 4144–4153.

Gabut M, Mine M, Marsac C, Brivet M, Tazi J, Soret J . The SR protein SC35 is responsible for aberrant splicing of the E1α pyruvate dehydrogenase mRNA in a case of mental retardation with lactic acidosis. Mol Cell Biol 2005; 25: 3286–3294.

Moir RD, Martins RN, Bush AI, Small DH, Milward EA, Rumble BA et al. Human brain beta A4 amyloid protein precursor of Alzheimer's disease: purification and partial characterization. J Neurochem 1992; 59: 1490–1498.

Shen MR, Batzer MA, Deininger PL . Evolution of the master Alu gene(s). J Mol Evol 1991; 33: 311–320.

Liu H-X, Chew SL, Cartegni L, Zhang MQ, Krainer AR . Exon splicing enhancer motif recognized by human SC35 under splicing conditions. Mol Cell Biol 2000; 20: 1063–1071.

Pahlsson P, Spitalnik SL . The role of glycosylation in synthesis and secretion of beta-amyloid precursor protein by Chinese hamster ovary cells. Arch Biochem Biophys 1996; 331: 177–186.

Liu F, Su Y, Li B, Zhou Y, Ryder J, Gonzalez-DeWhitt P et al. Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5. FEBS Lett 2003; 547: 193–196.

Thakur MK, Mani ST . Estradiol regulates APP mRNA alternative splicing in the mice brain cortex. Neurosci Lett 2005; 381: 154–157.

Moir RD, Lynch T, Bush AI, Whyte S, Henry A, Portbury S et al. Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain. J Biol Chem 1998; 273: 5013–5019.

Caswell MD, Mok SS, Henry A, Cappai R, Klug G, Beyreuther K et al. The amyloid beta-protein precursor of Alzheimer's disease is degraded extracellularly by a Kunitz protease inhibitor domain-sensitive trypsin-like serine protease in cultures of chick sympathetic neurons. Eur J Biochem 1999; 266: 509–516.

Ho L, Fukuchi K, Yonkin SG . The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells. J Biol Chem 1996; 271: 30929–30934.

Kametani F, Tanaka K, Ishii T, Ikeda S, Kennedy HE, Allsop D . Secretory form of Alzheimer amyloid precursor protein 695 in human brain lacks β/A4 amyloid immunoreactivity. Biochem Biophys Res Commun 1993; 191: 392–398.

Grover D, Mukerji M, Bhatnagar P, Kannan K, Brahmachari SK . Alu repeat analysis in the complete human genome: trends and variations with respect to genomic composition. Bioinformatics 2004; 20: 813–817.

Kreahling J, Graveley BR . The origins and implications of Aluternative splicing. Trends Genet 2004; 20: 1–4.

Wallace MR, Andersen LB, Saulino AM, Gregory PE, Glover TW, Collins FS . A de novo Alu insertion results in neurofibromatosis type 1. Nature 1991; 353: 864–866.

Ganguly A, Dunbar T, Chen P, Godmilow L, Ganguly T . Exon skipping caused by an intronic insertion of a young Alu Yb9 element leads to severe hemophilia A. Hum Genet 2003; 113: 348–352.

Claverie-Martin F, Flores C, Anton-Gamero M, Gonzalez-Acosta H, Garcia-Nieto V . The Alu insertion in the CLCN5 gene of a patient with Dent's disease leads to exon 11 skipping. J Hum Genet 2005; 50: 370–374.

Chen H, Hewison M, Hu B, Adams JS . Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance. Proc Natl Acad Sci USA 2003; 100: 6109–6114.

Xia H . Regulation of gamma-fibrinogen chain expression by heterogeneous nuclear ribonucleoprotein A1. J Biol Chem 2005; 280: 13171–13178.

Donev RM, Doneva TA, Bowen WR, Sheer D . HnRNP-A1 binds directly to double-stranded DNA in vitro within a 36 bp sequence. Mol Cell Biochem 2002; 233: 181–185.

Burd CG, Dreyfuss G . RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J 1994; 13: 1197–1204.

Bai Y, Lee D, Yu T, Chasin LA . Control of 3′ splice site choice in vivo by ASF/SF2 and hnRNP A1. Nucleic Acids Res 1999; 27: 1126–1134.

Blanchette M, Chabot B . Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J 1999; 18: 1939–1952.

Garcia-Blanco MA, Baraniak AP, Lasda EL . Alternative splicing in disease and therapy. Nat Biotechnol 2004; 22: 535–546.

Auboeuf D, Dowhan DH, Kang YK, Larkin K, Lee JW, Berget SM et al. Differential recruitment of nuclear receptor coactivators may determine alternative RNA splice site choice in target genes. Proc Natl Acad Sci USA 2004; 101: 2270–2274.

Shah YM, Basrur V, Rowan BG . Selective estrogen receptor modulator regulated proteins in endometrial cancer cells. Mol Cell Endocrinol 2004; 219: 127–139.

Martinez-Contreras R, Fisette J-F, Nasim FH, Madden R, Cordeau M, Chabot B . Intronic binding sites for hnRNP A/B and hnRNP F/H proteins stimulate pre-mRNA splicing. PLOS Biology 2006; 4: 172–185.